235 related articles for article (PubMed ID: 8650244)
21. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
22. Concordant loss of MTAP and p16/CDKN2A expression in gastroesophageal carcinogenesis: evidence of homozygous deletion in esophageal noninvasive precursor lesions and therapeutic implications.
Powell EL; Leoni LM; Canto MI; Forastiere AA; Iocobuzio-Donahue CA; Wang JS; Maitra A; Montgomery E
Am J Surg Pathol; 2005 Nov; 29(11):1497-504. PubMed ID: 16224217
[TBL] [Abstract][Full Text] [Related]
23. Methylthioadenosine phosphorylase gene is silenced by promoter hypermethylation in human lymphoma cell line DHL-9: another mechanism of enzyme deficiency.
Ishii M; Nakazawa K; Wada H; Nishioka J; Nakatani K; Yamada Y; Kamihira S; Kusunoki M; Nobori T
Int J Oncol; 2005 Apr; 26(4):985-91. PubMed ID: 15753993
[TBL] [Abstract][Full Text] [Related]
24. Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy.
Marcé S; Balagué O; Colomo L; Martinez A; Höller S; Villamor N; Bosch F; Ott G; Rosenwald A; Leoni L; Esteller M; Fraga MF; Montserrat E; Colomer D; Campo E
Clin Cancer Res; 2006 Jun; 12(12):3754-61. PubMed ID: 16778103
[TBL] [Abstract][Full Text] [Related]
25. Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Hellerbrand C; Mühlbauer M; Wallner S; Schuierer M; Behrmann I; Bataille F; Weiss T; Schölmerich J; Bosserhoff AK
Carcinogenesis; 2006 Jan; 27(1):64-72. PubMed ID: 16081515
[TBL] [Abstract][Full Text] [Related]
26. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas.
Illei PB; Rusch VW; Zakowski MF; Ladanyi M
Clin Cancer Res; 2003 Jun; 9(6):2108-13. PubMed ID: 12796375
[TBL] [Abstract][Full Text] [Related]
27. Methylthioadenosine phosphorylase, a gene frequently codeleted with p16(cdkN2a/ARF), acts as a tumor suppressor in a breast cancer cell line.
Christopher SA; Diegelman P; Porter CW; Kruger WD
Cancer Res; 2002 Nov; 62(22):6639-44. PubMed ID: 12438261
[TBL] [Abstract][Full Text] [Related]
28. Methylthioadenosine phosphorylase (MTAP) in hearing: gene disruption by chromosomal rearrangement in a hearing impaired individual and model organism analysis.
Williamson RE; Darrow KN; Michaud S; Jacobs JS; Jones MC; Eberl DF; Maas RL; Liberman MC; Morton CC
Am J Med Genet A; 2007 Jul; 143A(14):1630-9. PubMed ID: 17534888
[TBL] [Abstract][Full Text] [Related]
29. 5'-Deoxy-5'-methylthioadenosine phosphorylase and p16INK4 deficiency in multiple tumor cell lines.
Della Ragione F; Russo G; Oliva A; Mastropietro S; Mancini A; Borrelli A; Casero RA; Iolascon A; Zappia V
Oncogene; 1995 Mar; 10(5):827-33. PubMed ID: 7898924
[TBL] [Abstract][Full Text] [Related]
30. Deletion of dinucleotide repeat (Delta 14 allele) in the methylthioadenosine phosphorylase (MTAP) promoter and the allelotype of MTAP promoter in the Japanese population.
Kadariya Y; Nishioka J; Nakatani K; Nakashima K; Nobori T
Jpn J Cancer Res; 2002 Apr; 93(4):369-73. PubMed ID: 11985785
[TBL] [Abstract][Full Text] [Related]
31. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
Yu J; Batova A; Shao L; Carrera CJ; Yu AL
Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
[TBL] [Abstract][Full Text] [Related]
32. Chemotherapy targeting methylthioadenosine phosphorylase (MTAP) deficiency in adult T cell leukemia (ATL).
Harasawa H; Yamada Y; Kudoh M; Sugahara K; Soda H; Hirakata Y; Sasaki H; Ikeda S; Matsuo T; Tomonaga M; Nobori T; Kamihira S
Leukemia; 2002 Sep; 16(9):1799-807. PubMed ID: 12200696
[TBL] [Abstract][Full Text] [Related]
33. Independent Loss of Methylthioadenosine Phosphorylase (MTAP) in Primary Cutaneous T-Cell Lymphoma.
Woollard WJ; Kalaivani NP; Jones CL; Roper C; Tung L; Lee JJ; Thomas BR; Tosi I; Ferreira S; Beyers CZ; McKenzie RCT; Butler RM; Lorenc A; Whittaker SJ; Mitchell TJ
J Invest Dermatol; 2016 Jun; 136(6):1238-1246. PubMed ID: 26872600
[TBL] [Abstract][Full Text] [Related]
34. MTAP gene deletion in endometrial cancer.
Wong YF; Chung TK; Cheung TH; Nobori T; Chang AM
Gynecol Obstet Invest; 1998; 45(4):272-6. PubMed ID: 9623796
[TBL] [Abstract][Full Text] [Related]
35. Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types.
Gursky S; Olopade OI; Rowley JD
Cancer Genet Cytogenet; 2001 Sep; 129(2):93-101. PubMed ID: 11566337
[TBL] [Abstract][Full Text] [Related]
36. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma.
Behrmann I; Wallner S; Komyod W; Heinrich PC; Schuierer M; Buettner R; Bosserhoff AK
Am J Pathol; 2003 Aug; 163(2):683-90. PubMed ID: 12875987
[TBL] [Abstract][Full Text] [Related]
37. Methylthioadenosine phosphorylase cDNA transfection alters sensitivity to depletion of purine and methionine in A549 lung cancer cells.
Hori H; Tran P; Carrera CJ; Hori Y; Rosenbach MD; Carson DA; Nobori T
Cancer Res; 1996 Dec; 56(24):5653-8. PubMed ID: 8971171
[TBL] [Abstract][Full Text] [Related]
38. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.
Jagasia AA; Block JA; Qureshi A; Diaz MO; Nobori T; Gitelis S; Iyer AP
Cancer Lett; 1996 Jul; 105(1):91-103. PubMed ID: 8689637
[TBL] [Abstract][Full Text] [Related]
39. Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion.
Hustinx SR; Leoni LM; Yeo CJ; Brown PN; Goggins M; Kern SE; Hruban RH; Maitra A
Mod Pathol; 2005 Jul; 18(7):959-63. PubMed ID: 15832197
[TBL] [Abstract][Full Text] [Related]
40. Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.
Hustinx SR; Hruban RH; Leoni LM; Iacobuzio-Donahue C; Cameron JL; Yeo CJ; Brown PN; Argani P; Ashfaq R; Fukushima N; Goggins M; Kern SE; Maitra A
Cancer Biol Ther; 2005 Jan; 4(1):83-6. PubMed ID: 15662124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
